Viewing Study NCT05655312

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:45 PM
Ignite Modification Date: 2025-12-26 @ 10:45 PM
Study NCT ID: NCT05655312
Status: RECRUITING
Last Update Posted: 2025-10-17
First Post: 2022-11-15
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Sponsor: Perspective Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Melanoma (Skin) View
None Metastatic Melanoma View
None Melanoma Stage IV View
None Melanoma Stage III View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Melanoma View
None Theranostic View
None Radiopharmaceutical View
None Radiotherapy View
None Alpha Particle View
None Melanocortin Receptor Sub-type 1 (MC1R) View
None VMT01-T101 View
None Pb-203 View
None Pb-212 View
None Ga-68 View
None Nivolumab View